FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/104434 [Registered on: 20/02/2026] Trial Registered Prospectively
Last Modified On: 20/02/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of Shivagutika Herbal Treatment on Liver Health in Patients with Non-Alcoholic Fatty Liver Disease 
Scientific Title of Study   An Open-Label Randomized Controlled Clinical Study to Evaluate the Effect of Shivagutika Rasayana versus Sharapunkadi Churna in the Management of Non-Alcoholic Fatty Liver Disease w.s.r. to Kaphaja Yakritodara 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shreyashri N Suvarna 
Designation  Assistant Professor 
Affiliation  SDM College of Ayurveda Hospital and Research Centre Udupi 
Address  SDM College of Ayurveda Hospital and Research Centre, Kuthpady Udupi
SDM College of Ayurveda Hospital and Research Centre, Kuthpady Udupi
Udupi
KARNATAKA
574118
India 
Phone  9036441400  
Fax    
Email  shreyashravan91@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Shreyashri N Suvarna 
Designation  Assistant Professor 
Affiliation  SDM College of Ayurveda Hospital and Research Centre Udupi 
Address  SDM College of Ayurveda Hospital and Research Centre, Kuthpady Udupi
SDM College of Ayurveda Hospital and Research Centre, Kuthpady Udupi
Udupi
KARNATAKA
574118
India 
Phone  9036441400  
Fax    
Email  shreyashravan91@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Shreyashri N Suvarna 
Designation  Assistant Professor 
Affiliation  SDM College of Ayurveda Hospital and Research Centre Udupi 
Address  SDM College of Ayurveda Hospital and Research Centre, Kuthpady Udupi
SDM College of Ayurveda Hospital and Research Centre, Kuthpady Udupi
Udupi
KARNATAKA
574118
India 
Phone  9036441400  
Fax    
Email  shreyashravan91@gmail.com  
 
Source of Monetary or Material Support  
SDM College of Ayurveda Hospital and Reseach Centre Udupi 574118 
 
Primary Sponsor  
Name  SDM College of Ayurveda Hospital and Reseach Centre Udupi 
Address  SDM College of Ayurveda Hospital and Reseach Centre Udupi 574118 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
SHREYASHRI N SUVARNA  SRI DHARMASTHALA MANJUNATHESHWARA AYURVEDA HOSPITAL UDUPI  Department of Kayachikitsa, OPD No. 7, SDM COLLEGE OF AYURVEDA HOSPITAL AND RESEARCH CENTRE, LAXMINARAYANA NAGARA, KUTHPADY UDUPI- 574118
Udupi
KARNATAKA 
9036441400

shreyashravan91@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
The Institutional Human Ethical Committee SDMCAH&RU  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K760||Fatty (change of) liver, not elsewhere classified. Ayurveda Condition: YAKRUDDALYUDARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: SHIVAGUTIKA, Reference: ASTANGA SANGRAHA, UTTHARASTHANA, ADHYAYA 49:169, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 4(g), Frequency: tds, Bhaishajya Kal: Abhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: USHNAJALA), Additional Information: Haritaki Churna 3-5gms will be administered for Koshtashodhana.
2Comparator ArmDrugOther than Classical(1) Medicine Name: SHARAPUNKADI CHURNA, Reference: NA, Route: Oral, Dosage Form: Capsules, Dose: 1(g), Frequency: tds, Bhaishajya Kal: Abhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: Ushnajala), Additional Information: aritaki Churna 3-5gms will be administered for Koshtashodhana.
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patient fitting into the diagnostic criteria.
Subjects fit to undergo treatment protocol as per the study protocol and voluntarily
give written informed consent.  
 
ExclusionCriteria 
Details  Patients with history of alcohol intake.

Patients with recent positive history of other liver diseases such as viral hepatitis, autoimmune hepatitis, Wilsons disease, alpha 1 antitrypsin deficiency,
hemochromatosis.

Patients having fasting blood sugar (FBS) more than 200 mgdl and postprandial blood sugar
(PPBS) more than 250 mgdl, despite taking oral hypoglycemic agents, Stage II hypertension,
i.e., systolic blood pressure more than 160 mmHg and diastolic blood pressure more than 100 mmHg,
despite taking antihypertensive drugs

Any other conditions, which in the opinion of the investigator/s, makes the patient
unsuitable for enrollment or could interfere with his/her participation and completion
of the study.  
 
Method of Generating Random Sequence   Permuted block randomization, variable 
Method of Concealment   Centralized 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Assessment of changes in USG Abdomen for Liver
• Assessment of changes in the Biochemical analysis.
• Liver Function Test
• Lipid profile  
at Baseline, 8th week 
 
Secondary Outcome  
Outcome  TimePoints 
Objective Parameters
• Body Mass Index (BMI)
• Blood Pressure
• Waist Circumference
• BRAD Score
• Fib-4 Score
• Quality of life scale (WHO-QOL-BREF)
Subjective parameters
Symptoms of Kaphaja yakritodara & other metabolic symptoms
• Gauravata (Heaviness of the body)
• Aruchi(Loss of taste)
• Katinyata (Hardness of Abdomen)
• Avipaka(Indigestion)
• Dourbalya(Debility)
• Belching
• Vomiting
• Itching
• Abdominal heaviness
• Abdominal distension
• Flatulence
• Constipation
• Diarrhoea  
at Baseline, 8th week 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/04/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This study is the Randomized, Open Label, Parallel Group single centred trial comparing the efficacy of Shivagutika rasayana and Sharapunkadi Churna in 100 subjects with Non-Alcoholic Fatty Liver Disease in India. The study includes 63-65 days of intervention (mrudu virechana+medication) and 30 days of follow up period.   Total duration of study: 93-95 days. The primary outcome measures will be changes in USG Abdomen for Liver, Biochemical analysis including Liver Function Test and Lipid profile. Secondary outcome measures includes  Body Mass Index (BMI),  Blood Pressure,  Waist Circumference,  BRAD Score,  Quality of life scale (HRQoL).


 
Close